Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 15 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11903930

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  2. US 11905268

    Anthranilic acid derivatives and their use in the treatment of human cancers

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  3. US 11897875

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  4. US 11898158

    Methods and compositions for the treatment of lysosomal storage diseases

    Sangamo Therapeutics, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  5. US 11890290

    Topical treatment of wounds with statins and cholesterol for scar reduction

    Northwestern University · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  6. US 11890272

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  7. US 11892450

    Evaluation, assays and treatment of pKal-mediated disorders

    Takeda Pharmaceutical Company Limited · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  8. US 11891431

    Removal of serine proteases by treatment with finely divided silicon dioxide

    Takeda Pharm Limited ceutical Company Limited · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  9. US 11890415

    Airway management systems for pulmonary disorder treatment

    Covidien LP · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  10. US 11883381

    ASH1L inhibitors and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  11. US 11884731

    Vedolizumab for the treatment of fistulizing Crohn's disease

    Takeda Pharmaceutical Company Limited · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  12. US 11883492

    Combination treatment of chemoresistant cancers

    The Regents of the University of California · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  13. US 11878961

    Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

    The Board of Regents of the University of Texas System · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  14. US 11879017

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  15. US 11873490

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  16. US 11872312

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  17. US 11872200

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  18. US 11866450

    Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  19. US 11866727

    Materials and methods for treatment of glycogen storage disease type 1A

    CRISPR THERAPEUTICS AG · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  20. US 11865134

    Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  21. US 11865288

    Devices for applying a topical treatment

    THERMA BRIGHT INC · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  22. US 11865186

    Gene therapy treatment of atrial fibrillation

    Northwestern University · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  23. US 11857641

    Method for the treatment of mucopolysaccharidosis type I

    Sangamo Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  24. US 11857531

    Combination mast cell inhibition for treatment of BPH/LUTS

    Northwestern University · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted